ARCA biopharma (ABIO) director Grais received 6,000 Stock Option (right to buy)

Insider transactions reported

Linda Grais (director at ARCA biopharma Inc., ABIO) reported that they received 6,000 Stock Option (right to buy) on Jan 30, 2024.

Reporting person

Grais Linda

Options and other derivatives

Holdings before and after

• Stock Option (right to buy): 0 to 6,000 direct

Footnotes from the filing

1. 1. Grant to the Reporting Person of a stock option under the 2020 Equity Incentive Plan, vesting in 12 equal monthly installments beginning as of January 30, 2024, subject to the Reporting Person continuing to provide Continuous Service (as defined in the 2020 Equity Incentive Plan) through such date. If the Reporting Person's service as a director of the Issuer terminates in connection with or at any time following a change in control (for whatever reason), then any unexpired options that remain unvested shall become fully vested.

Transaction codes in this filing

Grant or award:

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ